Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Central Garden & Pet (NASDAQ:CENT) and its peers.

Household products stocks are generally stable investments, as many of the industry's products are essential for a comfortable and functional living space. Recently, there's been a growing emphasis on eco-friendly and sustainable offerings, reflecting the evolving consumer preferences for environmentally conscious options. These trends can be double-edged swords that benefit companies who innovate quickly to take advantage of them and hurt companies that don't invest enough to meet consumers where they want to be with regards to trends.

The 10 household products stocks we track reported a satisfactory Q2. As a group, revenues beat analysts’ consensus estimates by 1% while next quarter’s revenue guidance was 0.5% above.

The Fed cut its policy rate by 50bps (half a percent) in September 2024, the first in roughly four years. This marks the end of its most pointed inflation-busting campaign since the 1980s. While CPI (inflation) readings have been supportive lately, employment measures have bordered on worrisome. The markets will be assessing whether this rate cut's timing (and more potential ones in 2024 and 2025) is ideal for supporting the economy or a bit too late for a macro that has already cooled too much.

Thankfully, household products stocks have been resilient with share prices up 7.6% on average since the latest earnings results.

Central Garden & Pet (NASDAQ:CENT)

Enhancing the lives of both pets and homeowners, Central Garden & Pet (NASDAQ:CENT) is a leading producer and distributor of essential products for pet care, lawn and garden maintenance, and pest control.

Central Garden & Pet reported revenues of $996.3 million, down 2.6% year on year. This print was in line with analysts’ expectations, but overall, it was a mixed quarter for the company with an impressive beat of analysts’ organic revenue growth estimates but underwhelming earnings guidance for the full year.

"We delivered a solid third quarter earnings performance, recognizing that we had a record third quarter in 2023," said Beth Springer, Interim CEO.

Unsurprisingly, the stock is down 6.2% since reporting and currently trades at $35.65.

Is now the time to buy Central Garden & Pet? Access our full analysis of the earnings results here, it’s free.

Best Q2: Spectrum Brands (NYSE:SPB)

A leader in multiple consumer product categories, Spectrum Brands (NYSE:SPB) is a diversified company with a portfolio of trusted brands spanning home appliances, garden care, personal care, and pet care.

Spectrum Brands reported revenues of $779.4 million, up 6% year on year, outperforming analysts’ expectations by 3.8%. The business had a very strong quarter with an impressive beat of analysts’ operating margin and organic revenue growth estimates.

The market seems happy with the results as the stock is up 14.2% since reporting. It currently trades at $93.46.

Is now the time to buy Spectrum Brands? Access our full analysis of the earnings results here, it’s free.

Weakest Q2: Kimberly-Clark (NYSE:KMB)

Originally founded as a Wisconsin paper mill in 1872, Kimberly-Clark (NYSE:KMB) is now a household products powerhouse known for personal care and tissue products.

Kimberly-Clark reported revenues of $5.03 billion, down 2% year on year, falling short of analysts’ expectations by 1.3%. It was a slower quarter as it posted a miss of analysts’ organic revenue growth and gross margin estimates.

As expected, the stock is down 1.1% since the results and currently trades at $142.60.

Read our full analysis of Kimberly-Clark’s results here.

Clorox (NYSE:CLX)

Founded in 1913 with bleach as the sole product offering, Clorox (NYSE:CLX) today is a consumer products giant whose product portfolio spans everything from bleach to skincare to salad dressing to kitty litter.

Clorox reported revenues of $1.90 billion, down 5.7% year on year. This number came in 2.4% below analysts' expectations. Aside from that, it was a strong quarter as it produced an impressive beat of analysts’ organic revenue growth estimates.

Clorox had the weakest performance against analyst estimates and slowest revenue growth among its peers. The stock is up 23.1% since reporting and currently trades at $165.04.

Read our full, actionable report on Clorox here, it’s free.

Colgate-Palmolive (NYSE:CL)

Formed after the 1928 combination between toothpaste maker Colgate and soap maker Palmolive-Peet, Colgate-Palmolive (NYSE:CL) is a consumer products company that focuses on personal, household, and pet products.

Colgate-Palmolive reported revenues of $5.06 billion, up 4.9% year on year. This number topped analysts’ expectations by 1.1%. Overall, it was a strong quarter as it also produced an impressive beat of analysts’ organic revenue growth estimates and a narrow beat of analysts’ earnings estimates.

The stock is up 6% since reporting and currently trades at $102.33.

Read our full, actionable report on Colgate-Palmolive here, it’s free.

Join Paid Stock Investor Research

Help us make StockStory more helpful to investors like yourself. Join our paid user research session and receive a $50 Amazon gift card for your opinions. Sign up here.